ECA
CL icon

Elevated Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Elevated Capital Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$597 Sell
7
-9
-56% -$802 ﹤0.01% 776
2025
Q4 		$1.26K Buy
+16
New +$1.25K ﹤0.01% 686

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Elevated Capital Advisors's CL Position: Q1 2026 in Review

Elevated Capital Advisors reduced its Colgate-Palmolive (CL) stake by 56% in Q1 2026, selling an estimated $802 and leaving 7 shares worth $597. The position accounts for ﹤0.01% of the portfolio, ranked #776.

Elevated Capital Advisors first reported a position in CL in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.26K in Q4 2025. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Elevated Capital Advisors held 7 shares of Colgate-Palmolive worth $597 as of Q1 2026.
  • Elevated Capital Advisors sold 9 Colgate-Palmolive shares in Q1 2026, an estimated $802.
  • Colgate-Palmolive made up ﹤0.01% of Elevated Capital Advisors's portfolio in Q1 2026, its #776 holding.
  • Elevated Capital Advisors first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 2 quarters since.
  • Elevated Capital Advisors's Colgate-Palmolive position peaked at $1.26K in Q4 2025.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Elevated Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.